The Center for Health Research, Kaiser Permanente Northwest, 3800N. Interstate Ave., Portland, OR 97227, United States.
Vaccine. 2010 Nov 16;28(49):7713-5. doi: 10.1016/j.vaccine.2010.09.043. Epub 2010 Sep 25.
In 2008, potential temperature compromise of one lot of trivalent inactivated influenza vaccine (TIV) led to the revaccination of 13,210 Kaiser Permanente Northwest members within 28 days of receipt of their initial TIV dose. We conducted a retrospective cohort study to determine if these individuals experienced a higher rate of medically attended events (MAE) than those receiving only one TIV dose. We found no increase in MAE among those rapidly revaccinated (odds ratio 1.08; 95% confidence interval 0.80, 1.45), which may reassure individuals of the safety of revaccination with TIV should it be necessary, thereby leading to increased compliance with influenza vaccination recommendations.
2008 年,由于一批三价灭活流感疫苗(TIV)的潜在温度问题,在收到初始 TIV 剂量后 28 天内,13210 名 Kaiser Permanente Northwest 成员需要重新接种疫苗。我们进行了一项回顾性队列研究,以确定这些人是否比仅接受一剂 TIV 的人经历更高的医疗事件(MAE)发生率。我们发现,快速重新接种疫苗的人 MAE 没有增加(比值比 1.08;95%置信区间 0.80,1.45),这可能会让人们对 TIV 重新接种的安全性感到放心,如果有必要,从而提高对流感疫苗接种建议的遵从性。